gene patents
Breast cancer gene patents once again found valid by US appeals court
By Niklas Mattsson | Posted on August 23, 2012
In the “Myriad case” an ongoing legal battle with many twists and turns, the Court of Appeals for the Federal Circuit, CAFC, has decided to once again uphold patent claims covering isolated human genes BRCA1 and BRCA2, owned at least partly by Myriad Genetics Inc in Utah, USA. The patent claims were initially invalidated in...
Filed under: Insights
Tags: gene patents, USA
Controversial gene patents finally decided by the EPO
By Niklas Mattsson | Posted on November 27, 2008
During the last decade, the debate in Europe regarding the patentability of human gene inventions has been heavily influenced by “the Myriad case”, concerning patent applications by Myriad Genetics Inc (and others) that relate to the breast cancer susceptibility genes BRCA1 and BRCA2. Through two decisions spaced less than a week apart, the European Patent...
Tags: EPO, gene patents
Recent contributors
Counsel, AU and NZ Patent Attorney
Senior Associate, China Patent Attorney
Associate, Attorney at Law
Counsel, European Patent Attorney
Partner, Attorney at Law, Business Area Manager
Partner, European Patent Attorney